We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.27B
AUM Growth
+$170M
Cap. Flow
-$151M
Cap. Flow %
-4.62%
Top 10 Hldgs %
19.26%
Holding
132
New
3
Increased
35
Reduced
93
Closed
1

Top Buys

Rank Stock Value
1
NOG icon
Northern Oil and Gas
NOG
+$12.9M
2
LKQ icon
LKQ Corp
LKQ
+$5.23M
3
MODV
ModivCare
MODV
+$3.07M
4
CRNC icon
Cerence
CRNC
+$2.05M
5
ROG icon
Rogers Corp
ROG
+$1.62M

Top Sells

Rank Stock Value
1
SP
SP Plus Corporation
SP
+$20.9M
2
HURN icon
Huron Consulting
HURN
+$20.4M
3
MTSI icon
MACOM Technology Solutions
MTSI
+$16M
4
PTEN icon
Patterson-UTI
PTEN
+$10.6M
5
CHRS icon
Coherus Oncology
CHRS
+$8.76M

Sector Composition

Rank Sector Weight
1 Industrials 25.41%
2 Technology 18.57%
3 Healthcare 16%
4 Financials 13.89%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDMO
126
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4.79M 0.15%
736,741
+61,959
+9% +$399K
IWR icon
127
iShares Russell Mid-Cap ETF
IWR
$57.3B
$4.66M 0.14%
59,989
-3,029
-5% -$215K
NWL icon
128
Newell Brands
NWL
$2.61B
$4.37M 0.13%
503,695
-77,594
-13% -$592K
REI icon
129
Ring Energy
REI
$320M
$3.49M 0.11%
2,392,763
-20,462
-0.8% -$33.7K
EHAB
130
DELISTED
Enhabit
EHAB
$510K 0.02%
49,236
-385,241
-89% -$3.64M
IJH icon
131
iShares Core S&P Mid-Cap ETF
IJH
$126B
$7.93K ﹤0.01%
+145
New +$7.35K
CHRS icon
132
Coherus Oncology
CHRS
$228M
– –
-2,342,977
Closed -$8.76M
2 3 4 5
6

Similar funds

SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

Aristotle Capital Boston's Q4 2023 Portfolio in Review

As of Q4 2023, Aristotle Capital Boston held 132 positions worth $3.27B, up 5.5% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston withdrew a net $151M in Q4 2023, closing 1 position and reducing 93 holdings. Its most notable exit was Coherus Oncology, an estimated $8.76M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Northern Oil and Gas worth $12.6M.

  • Aristotle Capital Boston's largest Q4 2023 buy was Northern Oil and Gas: 339,979 shares worth $12.6M.
  • Aristotle Capital Boston added most to ModivCare in Q4 2023, an estimated $3.07M increase.
  • Aristotle Capital Boston's biggest Q4 2023 reduction was SP Plus Corporation, cutting an estimated $20.9M.
  • Aristotle Capital Boston fully exited Coherus Oncology in Q4 2023, selling an estimated $8.76M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $3.27B portfolio in Q4 2023.
  • Aristotle Capital Boston opened 3 new positions and closed 1 in Q4 2023.
  • Aristotle Capital Boston's portfolio value rose 5.5% quarter-over-quarter to $3.27B.

Based on Aristotle Capital Boston's 13F filing for Q4 2023, filed 14 Feb 2024.